Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer

Author:

Janczewski Lauren M.12,Logan Charles D.12ORCID,Vitello Dominic J.12,Buchheit Joanna T.12,Abad John D.13,Bentrem David J.123,Chawla Akhil123

Affiliation:

1. Department of Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA

2. Department of Surgery, Northwestern Quality Improvement, Research, & Education in Surgery (NQUIRES) Northwestern University Feinberg School of Medicine Chicago Illinois USA

3. Division of Surgical Oncology Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago Illinois USA

Abstract

AbstractBackground and ObjectivesNeoadjuvant chemotherapy (NAC) and chemoradiation (NCRT) have demonstrated improved survival for gastric cancer. However, the optimal neoadjuvant treatment remains unclear. We sought to evaluate perioperative and histopathologic outcomes among neoadjuvant treatments for locoregional gastric cancer.MethodsThe National Cancer Database queried patients who received NAC or NCRT followed by resection for T2‐T4 and/or node‐positive gastric cancer (2006–2018). Logistic and Poisson regression assessed perioperative (30‐day readmission, 30‐ and 90‐day mortality, length of stay [LOS]) and histopathologic outcomes (pathologic complete response [PCR], margin status, and negative pathologic lymph nodes [ypN0]). Kaplan–Meier methods and Cox regression assessed overall survival (OS).ResultsOf 9831 patients, 4221 (42.9%) received NAC and 5610 (57.1%) NCRT. There were no differences in perioperative outcomes, apart from patients treated with NCRT exhibiting increased LOS (incidence rate ratio 1.09, 95% confidence interval [CI] 1.03–1.16). Patients who received NCRT were more likely to achieve PCR, margin‐negative resection, and ypN0 (all p < 0.05). Median OS was 36.8 months for NAC and 33.6 months for NCRT (p < 0.001). NCRT independently predicted worse OS (vs. NAC, hazard ratio 1.10, 95% CI 1.03–1.18).ConclusionNCRT was associated with better histologic tumor response although NAC was associated with improved OS. Better understanding prognostication through histologic assessment following neoadjuvant therapy is needed.

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3